These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
716 related articles for article (PubMed ID: 8961976)
1. Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders. Hirvonen A; Saarikoski ST; Linnainmaa K; Koskinen K; Husgafvel-Pursiainen K; Mattson K; Vainio H J Natl Cancer Inst; 1996 Dec; 88(24):1853-6. PubMed ID: 8961976 [TBL] [Abstract][Full Text] [Related]
2. Inherited GSTM1 and NAT2 defects as concurrent risk modifiers in asbestos-related human malignant mesothelioma. Hirvonen A; Pelin K; Tammilehto L; Karjalainen A; Mattson K; Linnainmaa K Cancer Res; 1995 Jul; 55(14):2981-3. PubMed ID: 7606714 [TBL] [Abstract][Full Text] [Related]
3. Pooled analysis of NAT2 genotypes as risk factors for asbestos-related malignant mesothelioma. Betti M; Neri M; Ferrante D; Landi S; Biava A; Gemignani F; Bertolotti M; Mirabelli D; Padoan M; Ugolini D; Botta M; Bonassi S; Magnani C; Dianzani I Int J Hyg Environ Health; 2009 May; 212(3):322-9. PubMed ID: 18838334 [TBL] [Abstract][Full Text] [Related]
4. Metabolic genotypes as modulators of asbestos-related pleural malignant mesothelioma risk: a comparison of Finnish and Italian populations. Neri M; Taioli E; Filiberti R; Paolo Ivaldi G; Aldo Canessa P; Verna A; Marroni P; Puntoni R; Hirvonen A; Garte S Int J Hyg Environ Health; 2006 Jul; 209(4):393-8. PubMed ID: 16697254 [TBL] [Abstract][Full Text] [Related]
5. Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China. Song DK; Xing DL; Zhang LR; Li ZX; Liu J; Qiao BP Cancer Detect Prev; 2009; 32(5-6):416-23. PubMed ID: 19303722 [TBL] [Abstract][Full Text] [Related]
6. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. García-Closas M; Malats N; Silverman D; Dosemeci M; Kogevinas M; Hein DW; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Castaño-Vinyals G; Yeager M; Welch R; Chanock S; Chatterjee N; Wacholder S; Samanic C; Torà M; Fernández F; Real FX; Rothman N Lancet; 2005 Aug 20-26; 366(9486):649-59. PubMed ID: 16112301 [TBL] [Abstract][Full Text] [Related]
7. Modulation of DNA and protein adducts in smokers by genetic polymorphisms in GSTM1,GSTT1, NAT1 and NAT2. Godschalk RW; Dallinga JW; Wikman H; Risch A; Kleinjans JC; Bartsch H; Van Schooten FJ Pharmacogenetics; 2001 Jul; 11(5):389-98. PubMed ID: 11470992 [TBL] [Abstract][Full Text] [Related]
8. Glutathione S-transferase mu1 and N-acetyltransferase 2 genetic polymorphisms and exposure to tobacco smoke in nonsmoking and smoking lung cancer patients and population controls. Nyberg F; Hou SM; Hemminki K; Lambert B; Pershagen G Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):875-83. PubMed ID: 9796632 [TBL] [Abstract][Full Text] [Related]
9. [Role of gene polymorphisms of phase II of xenobiotic biotransformation from glutathione-S-transferase and N-acetyltransferase families in susceptibility to lung cancer among Mayak workers]. Rusinova GG; Azizova TV; Viazovskaia NS; Glazkova IV; Gur'ianov MIu; Osovets SV Radiats Biol Radioecol; 2014; 54(4):350-9. PubMed ID: 25775823 [TBL] [Abstract][Full Text] [Related]
10. N-Acetyltransferase genotypes as modifiers of diisocyanate exposure-associated asthma risk. Wikman H; Piirilä P; Rosenberg C; Luukkonen R; Kääriä K; Nordman H; Norppa H; Vainio H; Hirvonen A Pharmacogenetics; 2002 Apr; 12(3):227-33. PubMed ID: 11927838 [TBL] [Abstract][Full Text] [Related]
11. N-acetyltransferase (NAT1, NAT2) and glutathione S-transferase (GSTM1, GSTT1) polymorphisms in breast cancer. Lee KM; Park SK; Kim SU; Doll MA; Yoo KY; Ahn SH; Noh DY; Hirvonen A; Hein DW; Kang D Cancer Lett; 2003 Jul; 196(2):179-86. PubMed ID: 12860276 [TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms of phase II metabolic enzymes and lung cancer susceptibility in a population of Central South China. Chen HC; Cao YF; Hu WX; Liu XF; Liu QX; Zhang J; Liu J Dis Markers; 2006; 22(3):141-52. PubMed ID: 16788248 [TBL] [Abstract][Full Text] [Related]
13. Combined effect of smoking and inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 on bladder cancer in a Tunisian population. Rouissi K; Ouerhani S; Marrakchi R; Ben Slama MR; Sfaxi M; Ayed M; Chebil M; El Gaaied AB Cancer Genet Cytogenet; 2009 Apr; 190(2):101-7. PubMed ID: 19380028 [TBL] [Abstract][Full Text] [Related]
14. Synergistic effects of NAT2 slow and GSTM1 null genotypes on carcinogen DNA damage in the lung. Lee MS; Su L; Christiani DC Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1492-7. PubMed ID: 20501762 [TBL] [Abstract][Full Text] [Related]
15. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking. Okkels H; Sigsgaard T; Wolf H; Autrup H Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426 [TBL] [Abstract][Full Text] [Related]